
Phase 1b multicenter study of the safety and efficacy of stereotactic body radiation therapy for extracranial renal cell carcinoma metastases in combination with tyrosine kinase inhibitors or checkpoint inhibitors (VOLGA STUDY).
Author(s) -
Natalia Dengina,
Тимур Митин,
С. В. Гамаюнов,
Sufia Safina,
Ю М Крейнина,
И. В. Тимофеев
Publication year - 2019
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2019-9-3-57-64
Subject(s) - medicine , renal cell carcinoma , lesion , clinical endpoint , nivolumab , adverse effect , response evaluation criteria in solid tumors , target lesion , melanoma , radiology , oncology , clinical trial , phases of clinical research , urology , surgery , cancer , immunotherapy , cancer research , percutaneous coronary intervention , myocardial infarction